iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
6.92
+0.25 (3.83%)
At close: May 12, 2025, 4:00 PM
7.23
+0.31 (4.49%)
After-hours: May 12, 2025, 7:35 PM EDT
iTeos Therapeutics Market Cap
iTeos Therapeutics has a market cap or net worth of $264.85 million as of May 12, 2025. Its market cap has decreased by -30.09% in one year.
Market Cap
264.85M
Enterprise Value
-250.46M
1-Year Change
-30.09%
Ranking
Category
Stock Price
$6.92
Market Cap Chart
Since July 24, 2020, iTeos Therapeutics's market cap has decreased from $636.93M to $264.85M, a decrease of -58.42%. That is a compound annual growth rate of -16.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 255.09M | -9.08% |
| Dec 31, 2024 | 280.58M | -28.40% |
| Dec 29, 2023 | 391.85M | -43.60% |
| Dec 30, 2022 | 694.79M | -57.70% |
| Dec 31, 2021 | 1.64B | 38.57% |
| Dec 31, 2020 | 1.19B | 86.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |